1350687
Last Update Posted: 2011-05-10
Recruiting status is unknown
All Genders accepted | 18 Years-70 Years |
40 Estimated Participants | No Expanded Access |
Observational Study | Does not accept healthy volunteers |
Pulmonary Hypertension Prevention in Hemodialysis
Pulmonary hypertension is a new complication described in hemodialysis patients. in the last year these patients were treated by calcium carbonate orally to control serum phosphor. Calcium phosphor deposits in pulmonary artery can explain this phenomena. The investigators want to investigate the new phosphor non calcium containing agents in hemodialysis patients and to measure the pulmonary pressure.
The investigators will measure pulmonary blood pressure before and after treatment with new phosphor binders, non calcium containing.
Eligibility
Relevant conditions:
Chronic Kidney Disease
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov